Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01833 PA GOODDOCTOR
RTNominal down97.400 -2.500 (-2.503%)
Result Announcements

02/02/2021 16:50

Ping An Healthcare (01833) year loss widens to RMB948.48m

[ET Net News Agency, 2 February 2021] Ping An Healthcare and Technology Company Limited
(01833) said its loss attributable to owners of the company was RMB948.48 million for the
year ended 31 December 2020, compared to the loss of RMB733.86 million of the same period
last year. The basic loss per share was RMB0.92. No dividend will be distributed.
The revenue was RMB6.87 billion, a year-on-year increase of 35.55%. (RC)

Remark: Real time quote last updated: 12/04/2021 13:04
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.